Partner Content Partner Content SMi’s Europe’s Leading Ophthalmic Conference is only 2 weeks... Ophthalmic Drugs
Partner Content Partner Content SMi’s Ophthalmic Drugs Conference is only 4 weeks away! Only 4 Weeks Remain for Ophthalmic Drugs
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
